DIABNEXT was founded with the vision of developing highly innovative solutions that help people with diabetes better manage their chronic condition and improve their care and quality of life. Through collaboration with many leaders and clinicians in diabetes healthcare, the DIABNEXT platform offers patients a unique solution that enables remote monitoring, coordination, therapeutic education and analytics of data related to blood glucose, insulin, diet and physical activity automatically through connected health devices.
DIABNEXT was acquired by Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, in March 2022.
The DIABNEXT platform is now marketed under the name Glooko XT.
Company Details
- Employees
- 3
- Address
- 10, Rue Treilhard, Paris,île-De-France 75008,france
- Industry
- Wellness And Fitness Services
- NAICS
-
Fitness and Recreational Sports Centers
- Website
- diabnext.com
- HQ
- Paris, Île-de-France
Diabnext Questions
Diabnext's website is diabnext.com
Diabnext's LinkedIn profile is https://fr.linkedin.com/company/diabnext
Diabnext has
3 employees.
View email and phone details for 3
employees at Diabnext.
Diabnext's industry is
Wellness and Fitness Services
Diabnext's top competitors are
Dario,
Tidepool,
Insulet Corporation,
Glooko,
Tandem Diabetes Care,
Xbird Gmbh,
Omada Health,
Virta Health,
Inato,
Dexcom.
Diabnext's categories are Wellness and Fitness Services
